MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ijc.35395

Медицинская библиотека · International journal of cancer · 2025

Eye-sparing treatment for sinonasal tumors invading the orbit in the era of personalized therapy.

Wang Jie, Wang Li, Wang Tian, Tang Tianci, Li Yi, Li Qiang, Song Xinmao

СтатьяПеревод пока не подготовлен

Аннотация

Few studies investigated the eye-sparing treatment in patients with sinonasal carcinomas (SNCs) from the perspective of modern precision radiation, and the eye-sparing treatment in patients with grade III orbital invasion was rarely discussed. This retrospective study included patients with primary SNCs who accepted eye-sparing treatment from October 2000 to June 2022 at a single institution. Patients' clinical information and follow-up data (including visual data) were obtained. All patients underwent radio(chemo)therapy alone or with surgery. The primary outcomes were overall survival (OS) and progression-free survival (PFS) rates. Secondary outcomes included regional-failure-free survival (RFS) and distant metastasis-free survival (DMFS) rates. 42.7% of SNC patients (430/1006) had orbital invasion. Orbital invasion significantly decreased the 5-year OS (77.9% vs. 61.1%, p < .001), PFS (70.5% vs. 51.3%, p < .001), RFS (77.8% vs. 60.8%, p < .001), and DMFS (76.8% vs. 59.3%, p < .001), which worsened as the invasion grade increased. Stratified analysis by treatment indicated that surgery significantly improved the OS (p < .001) and PFS (p = .0031) in patients with grade I/II orbital invasion. In contrast, surgery conferred no benefits to OS (p = .14) and PFS (p = .16) in patients with grade III orbital invasion. Blindness occurred in 6.7% of patients with orbital involvement and 1.9% of patients without orbital involvement. There was no difference in the blindness ratio among different treatment modes (χ2 = 2.35, p = .31). Orbital invasion predicted poor survival outcomes, which worsened as the invasion grade increased. Surgery combined with radio(chemo)therapy was preferred in patients with grade I/II orbital invasion; however, surgery may have a limited effect on the survival of patients with grade III orbital invasion.

Для цитирования: Wang Jie, Wang Li, Wang Tian, Tang Tianci, Li Yi, Li Qiang, Song Xinmao. Eye-sparing treatment for sinonasal tumors invading the orbit in the era of personalized therapy.. International journal of cancer. 2025. DOI: 10.1002/ijc.35395.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.